Clinical trial
LDL Receptor Under Ezetimibe and Simvastatin
NCT00317993 · University of Cologne, Other · Completed
Key facts
| NCT number | NCT00317993 |
|---|---|
| Title | LDL Receptor Under Ezetimibe and Simvastatin |
| Official title | Effects of Ezetimibe and Simvastatin on LDL Receptor Protein Expression and on LDL Receptor and HMG-CoA Reductase mRNA Expression in Mononuclear Cells: a Randomized Controlled Study in Healthy Men |
| Lead sponsor | University of Cologne, Other |
| Collaborators | Merck Sharp & Dohme LLC Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Healthy Men |
| Intervention type | Drug |
| Interventions | ezetimibe, simvastatin, ezetimibe plus simvastatin |
| Enrollment | 60 |
| Start date | Apr 1, 2004 |
| Primary completion | Jul 1, 2004 |
| Completion | Jul 1, 2004 |
| First posted | Apr 25, 2006 |
| Last update posted | Dec 3, 2014 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: